Bharat Immunologicals & Biologicals Corporation Ltd. benchmarking: Perfomance to industry peers

Financial

	Bharat Immunological	Biofil Chem & Pharma	Makers Laboratories
Operational Metrics
Financials
5 yr Average ROE	-29.83 %	4.39 %	0.31 %
5yr average Equity Multiplier	3.08	2.06	2.36
5yr Average Asset Turnover Ratio	0.61	0.95	0.7
5yr Avg Net Profit Margin	-18.38 %	2.38 %	-0.21 %
Price to Book	1.05	3.19	0.98
P/E	0.0	23.65	0.0
5yr Avg Cash Conversion Cycle	206.63 Days	75.63 Days	75.08 Days
Inventory Days	125.06 Days	28.27 Days	107.1 Days
Days Receivable	61.4 Days	389.8 Days	71.83 Days
Days Payable	117.81 Days	203.89 Days	106.28 Days
5yr Average Interest Coverage Ratio	-2.32	23.53	4.73
5yr Avg ROCE	-44.64 %	6.37 %	6.35 %
5yr Avg Operating Profit Margin	-18.7 %	3.78 %	7.59 %
5 yr average Debt to Equity	0.71	0.03	0.21
5yr CAGR Net Profit	23.51 %	-14.7 %	n/a
5yr Average Return on Assets	-10.1 %	2.37 %	0.25 %
Shareholdings
Promoter Holding	59.25 %	46.79 %	61.27 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-0.03 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Bharat Immunological	Biofil Chem & Pharma	Makers Laboratories
Product Wise Break-Up	Product Wise Break-Up Oral Polio Vaccine 100.0 BIBSANIT 0 BIB VIT 0 Zinc Tablets 0 Chemicals Div 0 Pharma Div 0 Services 0 Chemicals 0 Generic Formulation 0	Product Wise Break-Up Services 0 BIB VIT 0 Chemicals 0 Pharmaceuticals 89.69 BIBSANIT 0 Zinc Tablets 0 Generic Formulation 0 Chemicals 10.31 Oral Polio Vaccine 0	Product Wise Break-Up Services 6.85 BIB VIT 0 Chemicals 63.85 Pharma Div 0 BIBSANIT 0 Zinc Tablets 0 Formulation 28.7 Chemicals Div 0 Oral Polio Vaccine 0 Others 0.6
Asset Break-Up	Asset Break-Up Oral Polio Vaccine 94.18 Zinc Tablets 0.04 BIB sweets Tablets 0 Chemicals 0 Pharmaceuticals 0 Others 5.78	-	Asset Break-Up Pharmaceuticals 33.37 Chemicals 66.63 Zinc Tablets 0 BIB sweets Tablets 0 Oral Polio Vaccine 0